New Leaf Ventures II, L.P. [Rocket]

Date Filed	Type	Description
02/10/2021	SC 13G/A	New Leaf Ventures II, L.P. reports a 0% stake in Neuronetics, Inc.
02/12/2020	SC 13G/A	New Leaf Ventures II, L.P. reports a 5.6% stake in Neuronetics, Inc.
02/12/2020	SC 13G/A	New Leaf Ventures II, L.P. reports a 2.9% stake in Principia Biopharma Inc.
02/13/2019	SC 13G	New Leaf Ventures II, L.P. reports a 11.1% stake in Principia Biopharma Inc.
02/13/2019	SC 13G	New Leaf Ventures II, L.P. reports a 8.8% stake in Neuronetics, Inc.
08/21/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/06/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/28/2017	SC 13D/A	Versartis, Inc. has filed a Schedule 13D for Versartis, Inc.
02/10/2017	SC 13G	New Leaf Ventures II, L.P. reports a 8.2% stake in iRhythm Technologies, Inc.
11/14/2016	SC 13D/A	Versartis, Inc. reports a 5.9% stake in Versartis, Inc.
11/06/2013	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/13/2012	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/01/2012	SC 13D	Durata Therapeutics, Inc. reports a 17.6% stake in Durata Therapeutics, Inc.
07/09/2012	SC 13D/A	New Leaf Ventures II, L.P. reports a 4.9% stake in Synageva BioPharma Corp.
03/28/2012	SC 13D/A	New Leaf Ventures II, L.P. reports a 6.5% stake in Synageva BioPharma Corp.
11/14/2011	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership
08/11/2011	SC 13D/A	New Leaf Ventures II, L.P. reports a 2.3% stake in Icagen, Inc.
07/29/2011	SC 13D	New Leaf Ventures II, L.P. reports a 2.7% stake in Icagen, Inc.
10/28/2010	SC 13D/A	New Leaf Ventures II, L.P. reports a 34.6% stake in World Heart Corporation
02/04/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/08/2008	SC 13D	Form SC 13D -- General statement of acquisition of beneficial ownership